- CH₣614.17m
- CH₣842.27m
- CH₣486.60m
- 63
- 27
- 22
- 28
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.1 | ||
| PEG Ratio (f) | 0.3 | ||
| EPS Growth (f) | 119.61% | ||
| Dividend Yield (f) | 4.67% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.32 | ||
| Price to Tang. Book | 8.88 | ||
| Price to Free Cashflow | 191.93 | ||
| Price to Sales | 1.26 | ||
| EV to EBITDA | 11.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.93% | ||
| Return on Equity | 0.06% | ||
| Operating Margin | 3.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CH₣m | 420.7 | 351.3 | 457.3 | 477.1 | 486.6 | 518.57 | 557.2 | 1.4% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -34.49 | -65.72 | +191.51 | -19.42 | -72.69 | +254.18 | +32.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medmix Systems AG is a Switzerland-based company active in manufacturing of high-precision delivery devices. The Company operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 20th, 2021
- Public Since
- September 30th, 2021
- No. of Shareholders
- 7,967
- No. of Employees
- 2,658
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
SIX Swiss Exchange- Shares in Issue
- 40,781,847
- Address
- Neuhofstrasse 20, BAAR, 6340
- Web
- Phone
- +41 417237300
- Auditors
- KPMG AG
Similar to MEDX
Alcon AG
SIX Swiss Exchange
COLTENE Holding AG
SIX Swiss Exchange
IVF Hartmann Holding AG
SIX Swiss Exchange
Medacta SA
SIX Swiss Exchange
Medartis Holding AG
SIX Swiss Exchange
FAQ
As of Today at 19:14 UTC, shares in medmix AG are trading at CH₣15.06. This share price information is delayed by 15 minutes.
Shares in medmix AG last closed at CH₣15.06 and the price had moved by -28.46% over the past 365 days. In terms of relative price strength the medmix AG share price has underperformed the FTSE Global All Cap Index by -32.83% over the past year.
The overall consensus recommendation for medmix AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The medmix AG dividend yield is 3.32% based on the trailing twelve month period.
Last year, medmix AG paid a total dividend of CH₣0.50, and it currently has a trailing dividend yield of 3.32%.Looking ahead, shares in medmix AG are due to go ex-dividend on 2024-04-26 and the next dividend pay date is 2024-04-30.
medmix AG are due to go ex-dividend on 2024-04-26 and the next dividend pay date is 2024-04-30. The historic dividend yield on medmix AG shares is currently 3.32%.
To buy shares in medmix AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CH₣15.06, shares in medmix AG had a market capitalisation of CH₣614.17m.
Here are the trading details for medmix AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: MEDX
Based on an overall assessment of its quality, value and momentum medmix AG is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in medmix AG is CH₣30.00. That is 99.2% above the last closing price of CH₣15.06.
Analysts covering medmix AG currently have a consensus Earnings Per Share (EPS) forecast of CH₣0.85 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like medmix AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -36.71%.
As of the last closing price of CH₣15.06, shares in medmix AG were trading -24.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The medmix AG PE ratio based on its reported earnings over the past 12 months is 16.1. The shares last closed at CH₣15.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on medmix AG's directors